News
BSX
48.83
+1.84%
0.88
What Is Driving Growth For Abbott Stock?
NASDAQ · 7h ago
Here's Why You Should Retain Boston Scientific (BSX) Now
NASDAQ · 22h ago
BSX November 17th Options Begin Trading
NASDAQ · 4d ago
Insider Sell: Boston Scientific
Insider Sell: Boston Scientific
MT Newswires · 4d ago
Looking Into Boston Scientific's Recent Short Interest
Benzinga · 03/10 19:15
Stocks most susceptible to a stronger Wealth Effect - BofA
Seeking Alpha · 03/09 12:54
Abbott (ABT) Makes Progress in the TAVI Space With Navitor
NASDAQ · 03/07 14:45
Abbott's (ABT) MitraClip Device Shows Favorable Outcome
NASDAQ · 03/07 13:03
Will Boston Scientific Stock See Higher Levels?
NASDAQ · 03/06 06:27
GE HealthCare Technologies: Good Growth Prospects And Potential For Valuation Multiple Re-Rating
Seeking Alpha · 03/03 17:55
Boston Scientific (BSX) Down 1.7% Since Last Earnings Report: Can It Rebound?
NASDAQ · 03/03 16:30
Here's Why Intuitive Surgical Stock Is A Better Pick Over Its Peer
NASDAQ · 03/02 05:54
BRIEF-Boston Scientific Corp - Co Entered Into A Second Amendment To $2.750 Billion Revolving Credit Agreement, Dated As Of May 10, 2021
Reuters · 03/01 22:31
Is Abbott Stock A Better Pick Over This Pharmaceuticals Bellwether?
NASDAQ · 02/27 06:02
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
NASDAQ · 02/24 13:50
Will Medtronic Stock See Higher Levels After An Upbeat Q3?
NASDAQ · 02/24 01:16
Analysts Anticipate 10% Upside For EPS
NASDAQ · 02/17 12:31
Boston Scientific (BSX) Gains From New Buyouts, Cost Woes Stay
NASDAQ · 02/16 15:50
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions. Its Urology and Neuromodulation business develops and manufactures devices to treat various urological, neurological movement disorders and pelvic conditions. Its Cardiac Rhythm Management develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment include Interventional Cardiology and Peripheral Interventions. Its Interventional Cardiology develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Its product offerings include 360 Clips and RESONATE, among others.